Adjuvant 5‐fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer

Adjuvant 5‐fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer

Abstract Background Although adjuvant gemcitabine (GEM) monotherapy improves the overall survival (OS) of patients with resected pancreatic cancer, its efficacy requires further improvement. This multicenter, phase II study investigated the efficacy of adjuvant portal vein infusion (PVI) chemotherap...

Full description

Saved in:
Bibliographic Details
Main Authors: Minoru Kitago, Yutaka Endo, Koichi Aiura, Yutaka Takigawa, Noriyuki Tani, Junichi Matsui, Keiichi Suzuki, Ryo Nishiyama, Yutaka Nakano, Yuta Abe, Hiroshi Yagi, Masahiro Shinoda, Osamu Itano, Minoru Tanabe, Yuko Kitagawa
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Cancer Medicine
Subjects:
adjuvant chemotherapy
gemcitabine
pancreatic ductal adenocarcinoma
resected pancreatic cancer
survival
Online Access:https://doi.org/10.1002/cam4.7459
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.7459

Similar Items